The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats

It has been widely accepted that resistant starch (RS) provides numerous health benefits for human. In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingshuang Lu, Renbing Qin, Jin Wang, Fengjuan Xiang, Yan Zhang, Bowei Zhang, Dancai Fan, Huan Lü, Xuemeng Ji, Shujun Wang, Shuo Wang
Format: Article
Language:English
Published: Tsinghua University Press 2024-11-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2023.9250008
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550079572312064
author Yingshuang Lu
Renbing Qin
Jin Wang
Fengjuan Xiang
Yan Zhang
Bowei Zhang
Dancai Fan
Huan Lü
Xuemeng Ji
Shujun Wang
Shuo Wang
author_facet Yingshuang Lu
Renbing Qin
Jin Wang
Fengjuan Xiang
Yan Zhang
Bowei Zhang
Dancai Fan
Huan Lü
Xuemeng Ji
Shujun Wang
Shuo Wang
author_sort Yingshuang Lu
collection DOAJ
description It has been widely accepted that resistant starch (RS) provides numerous health benefits for human. In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota profiles of type 2 diabetes mellitus (T2DM) rats. The T2DM model was established by streptozotocin injection to the high-fat-sugar fed rats. According to a serial of biochemical analyses, we found that RS5 diets were strongly correlated with enhanced homeostatic model assessment for insulin secretion (HOMA-IS), high-density lipoprotein cholesterol (HDL-C), adiponectin (ADP), insulin action index (IAI), glucagon-like peptide-1 (GLP1), and short-chain fatty acids (SCFAs) in T2DM rats whilst negatively associated with the low-density lipoprotein (LDL-C) and inflammatory cytokines, showing the capabilities to ameliorate T2DM symptoms by regulation of glucolipid metabolism, gut metabolites, and inflammation. On the other hand, RS2-enriched supplementations were influential in the mediation of insulin secretion to improve glucose metabolism. The increasing evidence collected herein suggested that intestinal microbiota could mediate glucolipids metabolism and alleviate inflammation after certain microflora nourished by RS. In addition, RS intake made an impact on phosphoinositide 3-kinase/protein kinase B signaling pathway that might contribute to the improvement of glucose metabolism, insulin resistance, and inflammatory responses.
format Article
id doaj-art-0bac6c866cbf4bf6a0fa40ec0c8c0932
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2024-11-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-0bac6c866cbf4bf6a0fa40ec0c8c09322025-01-10T06:57:02ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-11-011363210322310.26599/FSHW.2023.9250008The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus ratsYingshuang Lu0Renbing Qin1Jin Wang2Fengjuan Xiang3Yan Zhang4Bowei Zhang5Dancai Fan6Huan Lü7Xuemeng Ji8Shujun Wang9Shuo Wang10Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaSchool of Food Science, Henan Institute of Science and Technology, Xinxiang 453600, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaSchool of Food Science, Henan Institute of Science and Technology, Xinxiang 453600, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaState Key Laboratory of Food Nutrition and Safety, Tianjin University of Science & Technology, Tianjin 300457, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaIt has been widely accepted that resistant starch (RS) provides numerous health benefits for human. In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota profiles of type 2 diabetes mellitus (T2DM) rats. The T2DM model was established by streptozotocin injection to the high-fat-sugar fed rats. According to a serial of biochemical analyses, we found that RS5 diets were strongly correlated with enhanced homeostatic model assessment for insulin secretion (HOMA-IS), high-density lipoprotein cholesterol (HDL-C), adiponectin (ADP), insulin action index (IAI), glucagon-like peptide-1 (GLP1), and short-chain fatty acids (SCFAs) in T2DM rats whilst negatively associated with the low-density lipoprotein (LDL-C) and inflammatory cytokines, showing the capabilities to ameliorate T2DM symptoms by regulation of glucolipid metabolism, gut metabolites, and inflammation. On the other hand, RS2-enriched supplementations were influential in the mediation of insulin secretion to improve glucose metabolism. The increasing evidence collected herein suggested that intestinal microbiota could mediate glucolipids metabolism and alleviate inflammation after certain microflora nourished by RS. In addition, RS intake made an impact on phosphoinositide 3-kinase/protein kinase B signaling pathway that might contribute to the improvement of glucose metabolism, insulin resistance, and inflammatory responses.https://www.sciopen.com/article/10.26599/FSHW.2023.9250008resistant starchtype 2 diabetesglucolipid metabolismgut microbiotainflammation
spellingShingle Yingshuang Lu
Renbing Qin
Jin Wang
Fengjuan Xiang
Yan Zhang
Bowei Zhang
Dancai Fan
Huan Lü
Xuemeng Ji
Shujun Wang
Shuo Wang
The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
Food Science and Human Wellness
resistant starch
type 2 diabetes
glucolipid metabolism
gut microbiota
inflammation
title The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
title_full The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
title_fullStr The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
title_full_unstemmed The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
title_short The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
title_sort impact of the novel starch lipid complexes on the glucolipids metabolism inflammation and gut dysbiosis of type 2 diabetes mellitus rats
topic resistant starch
type 2 diabetes
glucolipid metabolism
gut microbiota
inflammation
url https://www.sciopen.com/article/10.26599/FSHW.2023.9250008
work_keys_str_mv AT yingshuanglu theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT renbingqin theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT jinwang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT fengjuanxiang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT yanzhang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT boweizhang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT dancaifan theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT huanlu theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT xuemengji theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT shujunwang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT shuowang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT yingshuanglu impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT renbingqin impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT jinwang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT fengjuanxiang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT yanzhang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT boweizhang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT dancaifan impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT huanlu impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT xuemengji impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT shujunwang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats
AT shuowang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats